BEYOND THE NORM: PROSTATE CANCER AWARENESS AND SCREENING PRACTICES IN PAKISTANI MEN AGED 40+ WITH AFFECTED FIRST-DEGREE RELATIVES, EMPLOYED AT A PRIVATE ORGANIZATION

Authors

  • Tahira Amjad Foundation University Islamabad-Pakistan https://orcid.org/0000-0002-8690-147X
  • Asfa Turab Foundation University Islamabad-Pakistan
  • Sadia Tameez-ud-din Foundation University Islamabad-Pakistan https://orcid.org/0009-0008-6383-7728
  • Fatima Iftikhar Foundation University Islamabad-Pakistan
  • Shoaib Ashraf Foundation University Islamabad-Pakistan
  • Shumaila Humayun Foundation University Islamabad-Pakistan
  • Ali Hassan Foundation University Islamabad-Pakistan
  • Tehreem Zahra Foundation University Islamabad-Pakistan
  • Arham Jabbar Foundation University Islamabad-Pakistan
  • Ahad Zulfiqar Foundation University Islamabad-Pakistan
  • Zainab Mansoor Foundation University Islamabad-Pakistan
  • Iqra Ayaz Foundation University Islamabad-Pakistan

DOI:

https://doi.org/10.55519/JAMC-01-14326

Keywords:

Awareness; First Degree Relatives; Prostate cancer; Screening; PSA

Abstract

Background: Prostate cancer is the second most common cancer in men worldwide. In Pakistan, awareness and screening remain limited among high-risk men even with affected first-degree relatives. Evaluating knowledge and behaviours is essential for identifying gaps and improving early detection efforts. Objectives were to assess awareness and screening practices regarding prostate cancer, identify participants with affected first-degree relatives, explore perceived barriers and facilitators, and determine associations between awareness and screening behaviours. Methods: A cross-sectional exploratory study was conducted from May to September 2024 among 156 eligible male employees aged 40 years and above. Ethical approval and informed consent were obtained. Data were collected using a structured questionnaire via Google Forms and analysed using SPSS version 26. Results: Among 156 participants with mean age 49.81±5.61), 125 (80.15%) had inadequate awareness of prostate cancer. Secondary education was completed by 62 (39.74%), and 100 (64.10%) were permanently employed. Information sources included friends or family in 143 (91.7%) and healthcare professionals in 139 (89.1%). Only 5 (3.2%) had first-degree relatives (father) with prostate cancer, and 4 (2.6%) had a positive family history (two uncles and two cousins). Prostate screening was conducted yearly in only 7 (4.5%) participants, while out of 156, 149 (95.5%) never underwent screening due to lack of awareness 100 (64.1%) and expenses 96 (61.5%). Awareness campaigns were recommended by 99 (63.5%) and organizational support by 91 (58.3%). No significant association was found between awareness, education, family history, and screening practices. The questionnaire demonstrated good reliability (Cronbach’s Alpha 0.888). Conclusion: Most men did not have adequate awareness of Prostate Cancer and had low screening practices. Awareness campaigns and organizational support were perceived as the main facilitators.

Author Biography

Tahira Amjad, Foundation University Islamabad-Pakistan

Associate Prof 

Community Medicine and Public Health Department

Foundation University Medical College Islamabad

References

1. Urology Care Foundation. Prostate cancer: symptoms, diag-nosis & treatment [Internet]. Linthicum (MD): Urology Care Foundation; [cited 2025 Feb 15]. Available from: https://www.urologyhealth.org/urology-a-z/p/prostate-cancer

2. Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 2016;43(3):289–97.

3. Teoh JYC. To all men with urinary symptoms – seek help early! Prostate Cancer Prostatic Dis 2023;26(3):449–50.

4. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73(1):17–48.

5. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74(1):12–49.

6. Prostate cancer: Symptoms, treatment, and causes [Internet]. [cited 2025 Jan 15]. Available from: https://www.medicalnewstoday.com/articles/150086

7. Ito K, Kimura T. Complex epidemiology of prostate cancer in Asian countries. Korean J Urol Oncol 2023;21(1):5–13.

8. Narod S. Genetic epidemiology of prostate cancer. Biochim Biophys Acta Rev Cancer. 1999;1423(1):F1–13.

9. Tipre M, Hardy C, Bowman T, Glover M, Gullet P, Baity D, et al. Concept mapping with Black men: barriers to prostate cancer screening and solutions. J Cancer Educ 2023;38(6):1808–15.

10. Ferlay J, Laversanne M, Ervik M, et al. Global Cancer Obser-vatory: cancer tomorrow, [Internet]. Lyon, France: Interna-tional Agency for Research on Cancer; 2020 [cited 2025 April 22]. Available from: https://gco.iarc.fr/tomorrow

11. Jenkins KR, Oyekunle T, Howard LE, Wiggins EK, Freedland SJ, Allott EH. Family history of prostate cancer and prostate tumor aggressiveness in Black and non-Black men: results from an equal access biopsy study. Cancer Causes Control 2021;32(4):337–46.

12. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 1992;89(8):3367–71.

13. Lamy PJ, Trétarre B, Rebillard X, Sanchez M, Cénée S, Mé-négaux F. Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study. Oncotarget 2018;9(34):23661–9.

14. Akhtar S, Hassan F, Ahmad S, El-Affendi MA, Khan MI. The prevalence of prostate cancer in Pakistan: a systematic re-view and meta-analysis. Heliyon 2023;9(10):e20350.

15. van Harten MJ, Roobol MJ, van Leeuwen PJ, Willemse PPM, van den Bergh RCN. Evolution of European prostate cancer screening protocols and summary of ongoing trials. BJU Int 2024;134(1):31–42.

16. Bratt O, Godtman RA, Jiborn T, Wallström J, Akre O, Carls-son S, et al. Population-based organised prostate cancer test-ing: results from the first invitation of 50-year-old men. Eur Urol 2024;85(3):207–14.

17. Boschheidgen M, Albers P, Schlemmer HP, Hellms S, Bon-ekamp D, Sauter A, et al. Multiparametric magnetic reso-nance imaging in prostate cancer screening at the age of 45 years: results from the first screening round of the PROBASE trial. Eur Urol 2024;85(2):105–111.

18. Schoen EJ, Baker JC, Colby CJ, To TT. Cost-benefit analysis of universal tandem mass spectrometry for newborn screen-ing. Pediatrics 2002;110(4):781–6.

19. Tanveer M, Tahir F, Majid Z, Mustafa Hussain M, Ali Asghar S, Qadar LT, et al. Awareness and self-care practices of elder-ly men regarding prostate diseases in Karachi, Pakistan. Cu-reus 2019;11(5): e4617.

20. Keeney E, Sanghera S, Martin RM, Gulati R, Wiklund F, Walsh EI, et al. Cost-effectiveness analysis of prostate cancer screening in the UK: a decision model analysis based on the CAP trial. Pharmacoeconomics 2022;40(12):1207–20.

21. Onyeodi IA, Akintelure S, Oladipo AT, Fashola TO. Knowledge, attitude, and screening practices of prostate can-cer among men in an urban community in Lagos, Nigeria. J Community Med Prim Health Care 2022;34(3):82–97.

22. Necku JG, Anaba EA, Abuosi AA. Prostate cancer awareness and attitude toward early detection among male soldiers in Ghana: a cross-sectional study. Afr J Urol 2019;25(5):1–6.

23. Zhang W, Cao G, Wu F, Wang Y, Liu Z, Hu H, et al. Global burden of prostate cancer and association with socioeconom-ic status, 1990–2019: a systematic analysis from the Global Burden of Disease Study. J Epidemiol Glob Health 2023;13(3):407–21.

24. Mbugua RG, Karanja S, Oluchina S. Barriers and facilitators to uptake of prostate cancer screening in a Kenyan rural community. Ann Afr Surg 2021;18(3):130–6.

25. Atuhe I, Jatho A, Nalwadda B, Basaza-Ejiri AH, Atuyambe L, Orem J. Barriers to and facilitators of prostate cancer screen-ing among men in Uganda prisons. Ecancermedicalscience 2023; 17:1563.

Published

2025-03-15

How to Cite

1.
Amjad T, Turab A, Tameez-ud-din S, Iftikhar F, Ashraf S, Humayun S, et al. BEYOND THE NORM: PROSTATE CANCER AWARENESS AND SCREENING PRACTICES IN PAKISTANI MEN AGED 40+ WITH AFFECTED FIRST-DEGREE RELATIVES, EMPLOYED AT A PRIVATE ORGANIZATION. J Ayub Med Coll Abbottabad [Internet]. 2025 Mar. 15 [cited 2025 May 23];37(1). Available from: https://www.jamc.ayubmed.edu.pk/index.php/jamc/article/view/14326

Issue

Vol. 37 No. 1 (2025): JOURNAL OF AYUB MEDICAL COLLEGE ABBOTTABAD

Section

ORIGINAL ARTICLE

License

Copyright (c) 2025 Tahira Amjad, Asfa Turab, Sadia Tameez-ud-din, Fatima Iftikhar, Shoaib Ashraf, Shumaila Humayun, Ali Hassan, Tehreem Zahra, Arham Jabbar, Ahad Zulfiqar, Zainab Mansoor, Iqra Ayaz

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.